Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.9300
-0.4400 (-32.12%)
At close: Aug 14, 2026, 4:00 PM EDT
0.8995
-0.0305 (-3.28%)
After-hours: Aug 14, 2026, 7:59 PM EDT
Daré Bioscience Employees
As of December 31, 2025, Daré Bioscience had 24 total employees, including 21 full-time and 3 part-time employees. The number of employees increased by 1 or 4.35% compared to the previous year.
Employees
24
Change (1Y)
1
Growth (1Y)
4.35%
Revenue / Employee
$56,914
Profits / Employee
-$457,798
Market Cap
13.93M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 24 | 1 | 4.35% | 21 | 3 |
| Dec 31, 2024 | 23 | -3 | -11.54% | 21 | 2 |
| Dec 31, 2023 | 26 | -4 | -13.33% | 23 | 3 |
| Dec 31, 2022 | 30 | 2 | 7.14% | 25 | 5 |
| Dec 31, 2021 | 28 | 5 | 21.74% | 20 | 8 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Citius Pharmaceuticals | 23 |
| Werewolf Therapeutics | 14 |
| Cellectar Biosciences | 11 |
| Cocrystal Pharma | 10 |
| Neuphoria Therapeutics | 8 |
| Allarity Therapeutics | 8 |
| Tempest Therapeutics | 5 |
DARE News
- 22 hours ago - Daré Bioscience Announces Pricing of $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 1 day ago - Daré Bioscience Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Daré Bioscience Quarterly report: Q2 2026 - Filings
- 1 day ago - Daré Bioscience Earnings release: Q2 2026 - Filings
- 1 day ago - Daré Bioscience Reports Second Quarter 2026 Results and Highlights Commercial Inflection as Multi-Product Women's Health Strategy Advances - GlobeNewsWire
- 9 days ago - Daré Bioscience to Host Second Quarter 2026 Financial Results and Company Update Conference Call and Webcast on August 13, 2026 - GlobeNewsWire
- 18 days ago - Daré Bioscience Expands Access Options for DARE to PLAY™ and Specialized Menopause Care Through Strategic Collaboration with MyMenopauseRx - GlobeNewsWire
- 26 days ago - Daré Bioscience Launches Nationwide Virtual Bus Tour Webinar Series to Showcase Commercial Strategy and Growth Opportunities - GlobeNewsWire